Tinlarebant has previously been granted Fast Track and Rare Pediatric Disease Designations in the U.S., Orphan Drug ...

Eton Pharmaceuticals is able to buy orphan drugs from large pharma companies, where they are too small to matter. Read why ...

Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi's M42 alongside strategic partnership Close of $76m Series B-1 tranche follows recent announcement of groundbreaking ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Is there anyone who thinks prescription drug prices in America are about right? President Trump has elevated an issue ...

The FDA recently granted orphan drug and rare pediatric disease designations to Infinant Health for a live biotherapeutic ...

Schrödinger, which makes software for drug development and materials design, said Tuesday that its chief financial officer, Geoffrey Porges, was leaving by mutual agreement. Richie Jain, the senior ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

The U.S. Department of Health and Human Services said on Tuesday it would set drug prices pegged to the lowest level paid by ...

Biological agents have become cheaper, faster, and easier for adversaries to engineer and employ due to advancements in ...

Drugmakers will be expected to commit to aligning U.S. prices with the lowest price set in a group of peer nations for all ...

FDA biosimilar approvals reached a record 19 in 2024, with projections indicating that 2025 could surpass this milestone ...